經緯恆潤(688326.SH):基於英偉達Orin-X芯片的城市NOA方案將於今年底量產落地
格隆匯8月14日丨經緯恆潤(688326.SH)在投資者互動平臺表示,公司的智駕產品涵蓋低、中、高階:低階方面,公司L2一體機產品的出貨量持續高速增長,配套客戶及車型不斷增加,其中基於EyeQ6L的前視800萬像素一體機今年銷量持續走高;在中階的高速NOA方面,公司已量產了基於TDA4的產品,後續公司會量產基於Mobileye方案的產品;在高階方面,公司有EyeQ6以及英偉達、輝羲的方案,其中基於英偉達Orin-X芯片的城市NOA方案將於今年底量產落地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.